openPR Logo
Press release

Pharmerging Contract Manufacturing Market : Overall Growth, Major Industry Leaders & Future Insights

11-21-2018 02:24 PM CET | Health & Medicine

Press release from: Future Market Insights

Pharmerging Contract Manufacturing Market : Overall Growth,

Pharmerging markets indicate the most promising emerging markets in the pharmaceutical domain. Most of these markets are currently exhibiting growth rates moderate to high indicating sustainable demand prospects. The global pharmaceutical market is projected to expand at CAGR of 4–7% between 2015 and 2026 to reach US$1.5 trillion by 2026. This indicates revenues from companies at ex-manufacturer price levels excluding rebates and discounts. Industry experts note that the U.S. and pharmerging markets are expected to account for more than 60% of sales and 80% of sales growth over the next five years. Contract manufacturing of pharmaceuticals is witnessing steady acceleration in pharmerging markets given high demand for medicines in these countries. For example, consumer medicines form a substantially large portion of pharmerging markets and manufacturers want to source the production of these medicines in the target market themselves. Given the growing complexity in supply-chain of highly potent drugs (both small molecules and biologics); there is a growing trend of outsourcing early-stage analytical, formulation, and commercial development of the medicines. This shift offers CDMOs more opportunities to partner and offer services within the drug product lifecycle. Specifically experts notes that outsourcing the bulk manufacturing of drugs is gradually gaining traction in countries in Asia-Pacific.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2482

Pharmerging Contract Manufacturing Market: Drivers and Restraints

Growing demand for generics in pharmerging markets due to affordability issues is the single most important revenue growth driver of the CMOs in pharmerging markets. Favorable government policies promoting localization are expected to create pull factors for generally manufacturers of generic products rather than originals. Companies having large portfolios, integrated distributors, strong stakeholder relationships, and quick decision-making processes in place are expected to witness dynamic growth compared to others. Other success factors of CMOs include proven record of accomplishment in continuity of supply, unchallengeable quality, competitive pricing and presence of adequate skilled workforce.

Barriers include non-availability of adequate sterile infrastructure to manufacture injectable drugs and other aseptic formulations. Availability of skilled labor to assist manufacturing of highly potent APIs, cytotoxic drugs, other biologics are factors expected to halt production. Other barriers include limited access to foreign capital, lack of transparency in emerging markets and fluctuations in government policies.

Pharmerging Contract Manufacturing Market: Segmentation

Global pharmerging contract manufacturing market can be segmented in multiple ways. A few these segmentation approaches are based on Product, Class, Therapeutic Area, and, CMO type.

Based on the product class, the pharmerging contract manufacturing market is segmented into the following:

Branded Drugs

Branded Generics

Generics

Based on the drug class, market is segmented as:

Small molecule Drugs

Generic Drugs

Highly-potent drugs and cytotoxic drugs

Large Molecule Drugs

Monoclonal Antibodies

Vaccines

Interferon

Insulin and analogs

Others

Based on the therapeutic class, the market is segmented into the following:

Cardiovascular

Oncology

Diabetes

Infectious Diseases

Others

Pharmerging Contract Manufacturing Market: Market Overview

The market for CMOs is gaining traction across regions and market given CMOs are increasingly being considered strategic partners, in production through sharing greater amounts of the portfolio volume, and less as step-in organizations to smooth out manufacturing peaks.

Geographically, pharmerging contract manufacturing market is classified into regions viz. Latin America, Europe, APAJ, Middle East and Africa. In terms of geography, Europe accounts for the largest market share followed by APAC. Favorable policies, regulations and sophisticated healthcare infrastructure with increasing FDA approvals is expected to drive revenue growth of the market in the near future. Markets in Asia Pacific represent the fastest growth for generic drugs owing to growing number of CMOs, CROs and CDMOs coupled with development of favorable infrastructure across countries in the region. It is predicted that much traction in solid dosage contract manufacturing could be noted in markets such as China and India as more facilities in these countries receive U.S. and EU CGMP certifications and approvals. Much activity is expected to be noted on both clinical and commercial phases over the near term in these pharmerging markets.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/toc/rep-gb-2482

Few key players in pharmerging contract manufacturing market are Cipla, Piramal Healthcare, Aurobindo, Jubilant Life Sciences, Zydus Cadila, Alkem, Intas, Lupin, Torrent, FDC, etc. apart from includes and others. Some of China’s leading CMOs include Asymchem Laboratories, Beijing Second Pharmaceutical, Chongqing Huapont Pharmaceutical, Porton Fine Chemicals, Shandong Xinhua Pharmaceutical, etc. These players are entering into strategic collaborations, mergers & acquisitions, and product portfolio expansions, which are their key sustainability strategies to maintain their profit margins in the long run. Also many startup companies’ have entered in this lucrative market space to capitalize over the opportunities present in therapeutic laser system market.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmerging Contract Manufacturing Market : Overall Growth, Major Industry Leaders & Future Insights here

News-ID: 1389462 • Views:

More Releases from Future Market Insights

Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
The Anesthesia Equipment Market is witnessing robust growth, with its value estimated at USD 9.3 billion in 2025 and projected to nearly double to USD 18.2 billion by 2035. This growth trajectory represents a compound annual growth rate of 7.0%, driven by increasing surgical volumes, rising prevalence of chronic respiratory and cardiovascular disorders, and ongoing expansion of healthcare infrastructure. The market is undergoing transformative change, as both established manufacturers and
Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time
Electric Power Sports Market to Reach USD 18.5 Billion by 2035
Electric Power Sports Market to Reach USD 18.5 Billion by 2035
The global Electric Power Sports Market is on a fast track to transformation, as consumers, manufacturers, and policymakers align on one powerful goal: sustainable, high-performance recreational experiences. Valued at USD 10.3 billion in 2025, the market is projected to expand to USD 18.5 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.0%. This momentum is set to generate an absolute dollar opportunity of USD 8.2 billion over
Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovation and Consumer Demand Drive Growth
Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovatio …
The global hair straightener market is entering a transformative growth phase, as industry leaders and emerging brands alike innovate to meet rising consumer demand for advanced hair styling solutions. Valued at USD 7.1 billion in 2025, the market is projected to reach USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period. Between 2025 and 2030, the market is set to rise steadily

All 5 Releases


More Releases for Pharmerging

Pharmerging Market Surges With Growth in Emerging Pharmaceutical Economies
Pharmerging Market Overview The Pharmerging Market is projected to grow from USD 1.25 Trillion in 2025 to USD 2.2 Trillion by 2032, at a CAGR of 8.1% during the forecast period. Coherent Market Insights is pleased to release its latest Pharmerging Market research report, offering an in-depth analysis of the U.S. Pharmerging Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels, encompassing supply chain shifts,
Pharmerging Market to Witness Astonishing Growth by 2028
The Pharmerging Market size is expected to grow at an annual average of CAGR 11% during the forecast period (2023-2029). Pharmerging refers to a group of countries with low but fast growth in the pharmaceutical market. Growing healthcare spending coupled with increasing number of private hospitals is currently driving the global pharmerging market growth. In addition, high prevalence of numerous chronic diseases and increasing consumer awareness of early detection of
New Report Projects Strong Growth for Pharmerging Market
As per the market research report by TMR, in 2015, the global pharmerging market stood at US$552.8 mn and is predicted to reach a value of US$1.40 bn by 2024. The market is further anticipated to register a promising 11.30% CAGR from 2016 to 2024. In the last few years, Asia Pacific held a huge share of the pharmerging market and is estimated to remain in the same position over
Pharmerging Market : 2016 - 2024 Illuminated By New Report
Global Pharmerging Market: Snapshot The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market. View Report: https://www.transparencymarketresearch.com/pharmerging-market.html With the increasing incidence rate of various diseases, the
Pharmerging Market 2016-2024 Industry Size, Shares, Research Trends
Global Pharmerging Market: Snapshot The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market. With the increasing incidence rate of various diseases, the demand for
Global Pharmerging Market Research Report 2017
Global Pharmerging Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. This report on the global Pharmerging market is a rich data repository assembled with the aim of presenting before the reader a new viewpoint on the market’s present state and estimated future growth. The report compiles vast data quantitative as well as qualitative insights into the key elements of